Amanda Wagner
Chief Executive Officer @ Immunitas Therapeutics
About
Amanda joined Immunitas when it was founded in 2019 and became CEO shortly after the Series B in 2021. Immunitas is the 4th med/biotech startup that she has been a part of. Amanda started her career in sales and marketing, launching UpToDate into hospital networks. She transitioned to biotech R&D program management, managing teams that were pushing new therapies through preclinical testing and into clinical trials, eventually becoming the program executive for a JAK inhibitor for autoimmune disease. Amanda has also spent a significant portion of her career in Business and Corporate Development, and has worked on public and private financings as well as pharma partnering transactions.
United States
Cambridge
Pharmaceuticals
Cross-functional Team Leadership, Program Management, Strategic Planning, Business Development, Drug Development, Pharmaceutical Industry, Biotechnology, Management, Lifesciences, Drug Discovery, Clinical Trials, Data Analysis, Oncology, Technology Transfer, CRO, Clinical Development, Life Sciences
Experience

VP, Business Development & Product Strategy
Concert Pharmaceuticals, Inc.
Amanda Wagner's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.









